← FDA Drug Approvals (Drugs@FDA)
SPIRONOLACTONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT GENERICS · Approved 2014-04-23
Drug application
- FDA Application #
ANDA203253- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SPIRONOLACTONE
- Generic name
- SPIRONOLACTONE
- Active ingredients
- SPIRONOLACTONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- JUBILANT GENERICS
- Manufacturer
- Jubilant Cadista Pharmacuticals Inc.
- First approval
- 2014-04-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown